BioCentury | Apr 6, 2019
Finance

Big caps under pressure

...LHON) South Korean MFDS action Mid-2019 Savara Inc. (NASDAQ:SVRA) Molgradex Treat autoimmune pulmonary alveolar proteinosis (PAP...
BioCentury | Mar 28, 2019
Politics & Policy

Lawmakers launch probe into kickbacks to patient assistance programs

Sens. Chuck Grassley (R-Iowa) and Ron Wyden (D-Ore.) are collecting information to expose any biopharma companies that are illegally providing kickbacks to exploit charitable patient assistance programs (PAPs). Senate Finance Committee Chairman Grassley and Ranking...
BioCentury | Jan 16, 2019
Tools & Techniques

Researchers develop AI tool to improve screening for cervical cancer

...to identify from new images CIN2+ samples more accurately than five other tests, including the Pap...
BioCentury | May 25, 2018
Clinical News

Dendreon takes Provenge earlier in prostate cancer

...surveillance for prostate cancer. Provenge comprises autologous dendritic cells loaded with a fusion protein of prostatic acid phosphatase...
...Business: Cancer Molecular target: NA Description: Autologous dendritic cells loaded with a fusion protein of prostatic acid phosphatase...
BioCentury | May 18, 2018
Clinical News

Dendreon takes Provenge earlier in prostate cancer

...surveillance for prostate cancer. Provenge comprises autologous dendritic cells loaded with a fusion protein of prostatic acid phosphatase...
BioCentury | May 2, 2018
Distillery Techniques

Biomarkers

TECHNOLOGY: Gene profiling Tumor mutations of 22 genes could help diagnose prostate cancer, and mutations in two of them could help predict patient outcomes. Whole-genome sequencing of 112 primary and metastatic prostate cancer and matched...
BioCentury | Apr 17, 2018
Distillery Techniques

Assays and screens

...TECHNOLOGY: Diagnostic assays A method for detecting aneuploidy and mutations in 18 genes in Pap test...
...help diagnose ovarian and endometrial cancers. The method involves using multiplexed PCR-based template preparation of Pap...
...genes, including p53, BRAF, K-Ras (KRAS) and epidermal growth factor receptor (EGFR; ErbB1; HER1). In Pap...
BioCentury | Mar 10, 2018
Product Development

Defining progress

...Provenge is Sanpower Group Co. Ltd.’s autologous dendritic cells loaded with a fusion protein of prostatic acid phosphatase...
BioCentury | Jan 5, 2018
Clinical News

OncBioMune reports additional Phase I data for prostate cancer vaccine

...trial's primary endpoint is DLTs. Secondary endpoints include PSA doubling time and prostate acid phosphate (PAP...
...Indication: Treat prostate cancer Endpoint: Dose-limiting toxicities (DLTs); PSA doubling time and prostate acid phosphate (PAP...
BioCentury | Sep 7, 2017
Strategy

What if you build, but they don’t come

...healthcare, includes two types of screening tests: cytology-based screening, known as the Pap test or Pap...
Items per page:
1 - 10 of 251